Total Payments
$1,792
2024 Payments
$284.90
Companies
33
Transactions
90
Medicare Patients
3,485
Medicare Billing
$425,411
Payment Breakdown by Category
Food & Beverage$1,662 (92.8%)
Education$113.17 (6.3%)
Other$16.74 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,662 | 87 | 92.8% |
| Education | $113.17 | 2 | 6.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $16.74 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $271.11 | 10 | $0 (2020) |
| ABBVIE INC. | $170.19 | 10 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $157.74 | 8 | $0 (2024) |
| BOSTON SCIENTIFIC CORPORATION | $133.94 | 2 | $0 (2021) |
| GENZYME CORPORATION | $129.13 | 6 | $0 (2020) |
| EMD Serono, Inc. | $114.93 | 8 | $0 (2020) |
| Alexion Pharmaceuticals, Inc. | $113.86 | 2 | $0 (2024) |
| Allergan, Inc. | $98.83 | 7 | $0 (2020) |
| Lundbeck LLC | $64.31 | 4 | $0 (2020) |
| UCB, Inc. | $60.73 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $284.90 | 11 | Alexion Pharmaceuticals, Inc. ($100.00) |
| 2023 | $199.67 | 11 | Novartis Pharmaceuticals Corporation ($88.93) |
| 2022 | $90.90 | 6 | ABBVIE INC. ($46.48) |
| 2021 | $183.00 | 5 | BOSTON SCIENTIFIC CORPORATION ($122.92) |
| 2020 | $108.70 | 6 | Amgen Inc. ($43.16) |
| 2019 | $400.89 | 24 | Amgen Inc. ($98.05) |
| 2018 | $366.60 | 17 | Amgen Inc. ($129.90) |
| 2017 | $157.71 | 10 | EMD Serono, Inc. ($66.56) |
All Payment Transactions
90 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/22/2024 | Aucta Pharmaceuticals, Inc. | Motpoly XR (Drug) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: Central Nervous System | ||||||
| 10/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Neuropsychiatry | ||||||
| 10/02/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Neuroscience | ||||||
| 07/30/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2024 | Siemens Medical Solutions USA, Inc. | Biograph Vision 600 (8 Ring/64 CT) (Device) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: MI - Nuclear Medicine (incl. PETNET & MIBR) | ||||||
| 07/09/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: Neurology | ||||||
| 05/28/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Education | In-kind items and services | $100.00 | General |
| Category: Rare Disease | ||||||
| 04/18/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: NEUROSCIENCE | ||||||
| 04/09/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Neurology | ||||||
| 03/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: NEUROSCIENCE | ||||||
| 02/22/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Neurology | ||||||
| 10/30/2023 | Microtransponder, Inc. | — | Food and Beverage | Cash or cash equivalent | $21.88 | General |
| 10/18/2023 | Microtransponder, Inc. | — | Food and Beverage | Cash or cash equivalent | $13.11 | General |
| 10/09/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: Neurology | ||||||
| 09/19/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/09/2023 | Neurocrine Biosciences, Inc. | Ongentys (Drug), INGREZZA | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Neuropsychiatry | ||||||
| 07/26/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: Neurology | ||||||
| 07/19/2023 | GE HealthCare | — | Food and Beverage | Cash or cash equivalent | $11.13 | General |
| 05/30/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/01/2023 | GE HealthCare | — | Food and Beverage | Cash or cash equivalent | $13.98 | General |
| 04/28/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: Neurology | ||||||
| 10/13/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: HYPERHYDROSIS | ||||||
| 08/10/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $13.87 | General |
| Category: Neuroscience | ||||||
| 06/14/2022 | Biogen, Inc. | SPINRAZA (Biological) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 876 | 8,132 | $645,570 | $184,948 |
| 2022 | 19 | 992 | 5,740 | $408,858 | $95,454 |
| 2021 | 14 | 822 | 4,066 | $352,382 | $77,045 |
| 2020 | 15 | 795 | 4,358 | $344,582 | $67,963 |
Total Patients
3,485
Total Services
22,296
Medicare Billing
$425,411
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | Office | 2023 | 12 | 3,080 | $276,300 | $117,376 | 42.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 350 | 496 | $74,400 | $28,039 | 37.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 88 | 106 | $23,320 | $9,350 | 40.1% |
| 70553 | Mri scan of brain before and after contrast | Office | 2023 | 32 | 33 | $73,755 | $5,081 | 6.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 48 | 48 | $18,240 | $4,821 | 26.4% |
| 70551 | Mri scan of brain without contrast | Office | 2023 | 37 | 37 | $73,260 | $3,271 | 4.5% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 75 | 76 | $13,680 | $3,243 | 23.7% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 12 | 19 | $15,200 | $2,783 | 18.3% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 20 | 24 | $12,240 | $2,010 | 16.4% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 25 | 43 | $9,804 | $1,946 | 19.8% |
| A9585 | Injection, gadobutrol, 0.1 ml | Office | 2023 | 39 | 3,890 | $5,835 | $982.59 | 16.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 16 | $2,560 | $977.92 | 38.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 17 | 17 | $4,522 | $957.00 | 21.2% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 21 | 21 | $3,780 | $908.04 | 24.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 31 | 39 | $3,510 | $844.49 | 24.1% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 14 | 50 | $8,300 | $778.62 | 9.4% |
| 72141 | Mri scan of upper spinal canal without contrast | Office | 2023 | 13 | 13 | $19,734 | $705.05 | 3.6% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 15 | 62 | $6,200 | $661.85 | 10.7% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2023 | 15 | 62 | $930.00 | $213.58 | 23.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 348 | 531 | $79,650 | $31,909 | 40.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 141 | 164 | $36,080 | $14,658 | 40.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 105 | 105 | $39,900 | $12,768 | 32.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 41 | 41 | $12,300 | $5,550 | 45.1% |
| 70553 | Mri scan of brain before and after contrast | Office | 2022 | 30 | 31 | $69,285 | $4,975 | 7.2% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2022 | 14 | 29 | $23,200 | $4,646 | 20.0% |
About Dr. Susan Glenn, M.D
Dr. Susan Glenn, M.D is a Neurology healthcare provider based in Raleigh, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538191341.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Susan Glenn, M.D has received a total of $1,792 in payments from pharmaceutical and medical device companies, with $284.90 received in 2024. These payments were reported across 90 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($1,662).
As a Medicare-enrolled provider, Glenn has provided services to 3,485 Medicare beneficiaries, totaling 22,296 services with total Medicare billing of $425,411. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Raleigh, NC
- Active Since 07/06/2006
- Last Updated 04/01/2021
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1538191341
Products in Payments
- Aimovig (Biological) $271.11
- KESIMPTA (Drug) $132.13
- General - Pain Management (Device) $122.92
- Rebif (Biological) $101.76
- BOTOX (Biological) $101.70
- ULTOMIRIS (Biological) $100.00
- UBRELVY (Drug) $72.88
- LEMTRADA (Drug) $68.34
- AUBAGIO (Drug) $60.79
- NORTHERA (Drug) $47.26
- Briviact (Drug) $44.26
- XEOMIN (Biological) $34.97
- QULIPTA (Drug) $32.60
- GILENYA (Drug) $25.61
- BOTOX (Drug) $24.54
- BOTOX - NEUROLOGY (Drug) $24.46
- Gamunex-C (Biological) $24.03
- Horizant (Drug) $20.31
- INGREZZA (Drug) $19.13
- NUEDEXTA (Drug) $19.04
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Raleigh
John Scagnelli, M.d, M.D
Neurology — Payments: $434,945
Neurology $434,945
Dr. Tibor Becske, M.d, M.D
Neurology — Payments: $387,165
Neurology $387,165
Dr. Keith Hull, M.d, M.D
Neurology — Payments: $140,830
Neurology $140,830
Dr. Casey Jeffreys, M.d, M.D
Neurology — Payments: $70,215
Neurology $70,215
John Collins, M.d, M.D
Neurology — Payments: $25,595
Neurology $25,595
Dr. Kenneth Carnes, M.d, M.D
Neurology — Payments: $23,277
Neurology $23,277